Cancer Care Experiences, Resilience, and Psychological Symptoms Among Patients During the COVID-19 Pandemic: A Mixed-Methods Study

Oncology nursing forum, Год журнала: 2025, Номер 52(2), С. 97 - 112

Опубликована: Фев. 18, 2025

The aims of this study were to characterize patients' distress, psychological symptoms, and resilience during the COVID-19 pandemic, evaluate differences in experiences, resilience, symptoms patients with without distress. Convergent parallel mixed-methods. Semistructured interviews structured questionnaires. Interview transcripts analyzed using content analysis. Differences demographic clinical characteristics, depression, anxiety, identified chi-square, Fisher's exact, independent sample t tests. Joint displays facilitated data integration meta-inferences. Of 54 patients, 25 who distressed more likely have low exhibit anxiety report difficulty paying their bills, identify as Hispanic. A patient-centered approach cancer care which clinicians assess psychological, social, economic resources make referrals supportive services is warranted.

Язык: Английский

---

Racial Differences in Breast Cancer Survival Between Black and White Women According to Tumor Subtype: A Systematic Review and Meta-Analysis

Journal of Clinical Oncology, Год журнала: 2024, Номер unknown

Опубликована: Сен. 17, 2024

PURPOSE Despite effective early-detection approaches and innovative treatments, Black women in the United States have higher breast cancer mortality rates compared with White women. The purpose of this systematic review meta-analysis is to determine extent disparities survival between according tumor subtype. METHODS A comprehensive database search was performed for full-text, English-language articles published from January 1, 2000, December 31, 2022. Included studies female patients within subtypes defined by hormone receptor human epidermal growth factor 2 (HER2)/neu (HER2; now known as ERBB2) status. Random-effects models were used combine study-specific results generate pooled relative risks (RRs) 95% CIs cancer–specific or overall (OS). protocol registered PROSPERO (CRD42021268212). RESULTS Eighteen including 228,885 (34,262 Black; 182,466 White) identified. Compared women, had a risk death all subtypes. summary 50% among receptor-positive HER2-negative [HER2–] tumors (RR, 1.50 [95% CI, 1.30 1.72]), 34% receptor+/HER2+ 1.34 1.10 1.64]), 20% receptor–negative (–)/HER2+ 1.29 1.00 1.43]), 17% individuals receptor–/HER2– (hazard ratio, 1.17; 1.25). also poorer OS than CONCLUSION These suggest there are both subtype-specific subtype-independent mechanisms that contribute which require multilevel interventions address achieve health equity.

Язык: Английский

---

EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe

European Journal of Cancer, Год журнала: 2024, Номер 207, С. 114156 - 114156

Опубликована: Июнь 7, 2024

Язык: Английский

---

“First, Trust Needs to Develop”: Hematologists’ Perspectives on Factors Influencing Black Persons’ Participation in Clinical Trials

Journal of Racial and Ethnic Health Disparities, Год журнала: 2024, Номер unknown

Опубликована: Окт. 18, 2024

Язык: Английский

---

Ethical reflections on healthy aging

Ethics Medicine and Public Health, Год журнала: 2024, Номер 33, С. 101024 - 101024

Опубликована: Ноя. 13, 2024

Язык: Английский

---